Algocyte can bring blood testing into care homes and domiciliary settings which can support earlier identification of deterioration helping reduce potential high-cost emergencies
Samples must travel. Community teams balance maximising coverage against minimising haemolysis as bloods are stored and carried to distant labs.
Results lag. Clinicians often wait hours or days for results once samples reach the lab, a bottleneck that delays decisions.
Admissions mount. Care home residents attend A&E around once a year. 70% of those visits end in admission, and around 40% of those admissions are avoidable (Health Foundation), at an estimated £1.3bn annual cost to the NHS (modelled).
A patient small sample returns a full blood count on-site in under 20 minutes, with no sample transport and no haemolysis risk from storage. Community teams can do more on each visit, and clinicians see results the same day.
Meet Algocyte Proxima
Regular on-site testing supports earlier identification of deterioration, providing objective blood data alongside symptoms and lifestyle. It helps teams decide who can be cared for in the home and who needs escalation, with results reaching the GP and out-of-hours clinicians.
Inside Future Health Hub
Algocyte Proxima ships to the home or the community team with an agreed protocol. A patient small sample returns a full blood count in under 20 minutes, run by trained care or clinical staff. Results and trends flow to the clinician's dashboard.
Meet Algocyte ProximaFrom a small sample (venous, finger prick or shoulder patch), in under 20 minutes, run by healthcare professional (trained carers, community nurses, trained operators).
Future release will build a personal reference range for each resident or patient.
Physics-informed AI keeps in check each test for physical and biological relevancy.
The care team and GP see the same trend and decide whether to manage in place or escalate.
Book a 20-minute briefing with our team to see Algocyte in action.